Mylan’s life-saving epinephrine auto-injector EpiPen now has a generic rival, the Food and Drug Administration (FDA) triumphantly announced. Teva Pharmaceuticals USA now has FDA approval to market a ...

Sen. Patty Murray (D-WA) on Tuesday sent a letter to Mylan CEO Heather Bresch seeking more details, including e-mail communications, on the ways that Mylan attempted to keep Teva’s generic EpiPen from ...

Israel-based Teva Pharmaceuticals seeks to earn Food and Drug Administration approval for its generic version of Mylan’s EpiPen by late 2017 or early 2018. In February, the FDA failed to approve ...

EpiPen will face competition in a generic version of the auto-injector marketed by Teva Pharmaceuticals and approved by the U.S. Food and Drug Administration on Thursday. The FDA previously approved ...

The Denver-based federal appeals court confirmed on Friday that Colorado may be sued for an allegedly unconstitutional 2023 law aimed at capping the price of EpiPens for certain consumers. House Bill ...

For the first time ever, generic versions of the EpiPen are officially available. Here's what to know about the alternatives made by Teva Pharmaceuticals USA. Over the years, the price of EpiPens have ...

EpiPen, a life-saving allergy treatment widely criticized for its high price tag, will get generic competition for the first time since the autoinjector was approved more than two decades ago. The ...

(Reuters) - Teva Pharmaceutical Industries Ltd said on Tuesday its generic version of Mylan NV's EpiPen will have a wholesale price of $300. The Israeli drugmaker also said its version of the ...

TEL AVIV, Feb 19 (Reuters) - Teva Pharmaceutical Industries expects its generic version of Mylan's EpiPen to have about 25 percent of the U.S. market by the end of 2019, Chief Executive Kare Schultz ...

Please provide your email address to receive an email when new articles are posted on . 96.1% of caregivers said they know how to use their child’s autoinjector. 33.1% of caregivers removed the ...